HIZENTRA DM
Live / Applied — First extension granted (statement of use) (as of 03 Nov 2025)
What this means for you
Not registered yet, but its 06 Sept 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98736641
- Mark type
- Stylized text
- Filed
- 06 Sept 2024
- Published for opposition
- 08 Apr 2025
- Attorney of record
- Scott D. Woldow
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of immuno deficiency disorders; intravenous immunoglobulins for use in the treatment of immuno deficiency disorders and in immune replacement therapy; Pharmaceutical preparations for the treatment of dermatomyositis, inflammatory diseases and inflammatory conditions, muscle conditions and skin conditions; pharmaceutical preparations for the treatment of skin rash, weight loss, fever, lung conditions, light sensitivity, calcium deposits, and cardiovascular conditions; pharmaceutical preparations for the treatment of inflammatory myopathy and muscular conditions
Owner
- CSL Behring AG, Bern 22, CH
- CSL Behring AG, Bern 22, CH
Prior registrations
Prosecution history
- 03 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Nov 2025 — SOU EXTENSION 1 GRANTED
- 03 Nov 2025 — SOU EXTENSION 1 FILED
- 03 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Apr 2025 — PUBLISHED FOR OPPOSITION
- 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Mar 2025 — EXAMINER'S AMENDMENT ENTERED
- 13 Mar 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 13 Mar 2025 — EXAMINERS AMENDMENT E-MAILED
- 13 Mar 2025 — EXAMINERS AMENDMENT -WRITTEN
- 10 Mar 2025 — ASSIGNED TO EXAMINER
- 06 Sept 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED